BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38132702)

  • 1. Retrospective evaluation of clinical decision support for within-laboratory optimization of SARS-CoV-2 NAAT workflow.
    Durant TJS; Peaper DR
    J Clin Microbiol; 2024 Feb; 62(2):e0078523. PubMed ID: 38132702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of different SARS-CoV-2 assays on laboratory turnaround time.
    Marquis B; Opota O; Jaton K; Greub G
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33956591
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory information system requirements to manage the COVID-19 pandemic: A report from the Belgian national reference testing center.
    Weemaes M; Martens S; Cuypers L; Van Elslande J; Hoet K; Welkenhuysen J; Goossens R; Wouters S; Houben E; Jeuris K; Laenen L; Bruyninckx K; Beuselinck K; André E; Depypere M; Desmet S; Lagrou K; Van Ranst M; Verdonck AKLC; Goveia J
    J Am Med Inform Assoc; 2020 Aug; 27(8):1293-1299. PubMed ID: 32348469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.
    Safiabadi Tali SH; LeBlanc JJ; Sadiq Z; Oyewunmi OD; Camargo C; Nikpour B; Armanfard N; Sagan SM; Jahanshahi-Anbuhi S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs.
    Craney A; Petrik D; Suhku A; Qiu Y; Racine-Brzostek S; Rennert H; Piscatelli H; Rathnaiah G; Hangman A; Carrie M; Cushing M
    Microbiol Spectr; 2021 Sep; 9(1):e0008321. PubMed ID: 34378961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician satisfaction and emergency department laboratory test turnaround time.
    Steindel SJ; Howanitz PJ
    Arch Pathol Lab Med; 2001 Jul; 125(7):863-71. PubMed ID: 11419969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer.
    LeBlanc JJ; McCracken GR; Goodall B; Hatchette TF; Barrett L; Ross J; Davidson RJ; Patriquin G
    Microbiol Spectr; 2022 Aug; 10(4):e0063922. PubMed ID: 35863036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.
    Hohl CM; Hau JP; Vaillancourt S; Grant J; Brooks SC; Morrison LJ; Perry JJ; Rosychuk RJ;
    JAMA Netw Open; 2022 Oct; 5(10):e2236288. PubMed ID: 36223119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test.
    Katzman BM; Wockenfus AM; Kelley BR; Karon BS; Donato LJ
    Clin Biochem; 2023 Jul; 117():1-3. PubMed ID: 34798145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests.
    Delgado-Diaz DJ; Sakthivel D; Nguyen HHT; Farrokzhad K; Hopper W; Narh CA; Richards JS
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March-July 2020.
    Kaufman HW; Chen Z; Meyer WA; Wohlgemuth JG
    Popul Health Manag; 2021 Feb; 24(S1):S35-S42. PubMed ID: 33216694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-endoscopy coronavirus disease 2019 screening and severe acute respiratory syndrome coronavirus-2 nucleic acid amplification testing in the Veterans Affairs healthcare system: clinical practice patterns, outcomes, and relationship to procedure volume.
    Gawron AJ; Sultan S; Glorioso TJ; Califano S; Kralovic SM; Jones M; Kirsh S; Dominitz JA
    Gastrointest Endosc; 2022 Sep; 96(3):423-432.e7. PubMed ID: 35461889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
    Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
    J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis.
    Mustafa Hellou M; Górska A; Mazzaferri F; Cremonini E; Gentilotti E; De Nardo P; Poran I; Leeflang MM; Tacconelli E; Paul M
    Clin Microbiol Infect; 2021 Mar; 27(3):341-351. PubMed ID: 33188933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of High Throughput SARS-CoV-2 Antigen Testing Compared to Nucleic Acid Testing.
    Peck Palmer O; Hasskamp JH; La HS; Pramod Patwardhan P; Ghumman S; Baloda V; Jung Y; Wheeler SE
    Lab Med; 2023 Mar; 54(2):e54-e57. PubMed ID: 36065160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the STARlet workflow for semi-automatic SARS-CoV-2 screening of swabs and deep respiratory materials using the RealAccurate Quadruplex SARS-CoV-2 PCR kit and Allplex SARS-CoV-2 PCR kit.
    Flipse J; Tromp AT; Thijssen D; van Xanten-Jans-Beken N; Pauwelsen R; van der Veer HJ; Schlaghecke JM; Swanink CMA
    Microbiol Spectr; 2024 Feb; 12(2):e0329623. PubMed ID: 38193688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Turnaround Time for Group A
    Durant TJS; Merwede J; Reynolds J; Peaper DR
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31217271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings.
    Chong BSW; Tran T; Druce J; Ballard SA; Simpson JA; Catton M
    Pathology; 2020 Dec; 52(7):796-800. PubMed ID: 33036772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.